Pricing Log in Create free account

Vyome Holdings, Inc. (HIND) vs Tvardi Therapeutics, Inc. (TVRD)

Vyome Holdings, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Vyome Holdings, Inc. and Tvardi Therapeutics, Inc. are of similar size ($11.5M and $11.4M). Tvardi Therapeutics, Inc. grew revenue faster over the last twelve months: −55.3% against −67.1%. Tvardi Therapeutics, Inc. has the higher net margin (0.00% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Tvardi Therapeutics, Inc. leads on 11 and Vyome Holdings, Inc. on 5.

Valuation

Metric HIND TVRD Biotechnology median
P/E n/m n/m 10.60
P/S 86.52 1.20 9.40
P/B 1.54 1.09 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 124.04 6.98 9.02
Earnings yield (223.64%) (287.63%) (32.88%)
Free cash flow yield (49.67%) (309.54%) (23.13%)

Profitability

Metric HIND TVRD Biotechnology median
Gross margin 52.77% 146.85% 68.51%
Operating margin (9,184.82%) 0.00% 0.00%
Net margin (8,711.71%) 0.00% 0.00%
Free cash flow margin (4,298.00%) 0.00% 0.00%
Return on equity (172.10%) (126.19%) (51.96%)
Return on assets (124.23%) (85.08%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HIND TVRD Biotechnology median
Revenue growth (TTM) (67.10%) (55.30%) 6.76%
EPS growth (last fiscal year) 99.92% 71.45% 29.88%
Revenue growth, 5-year CAGR (50.98%) (18.53%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HIND TVRD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.37 1.87 4.97
Net debt to EBITDA 0.48 1.15 1.01

Dividend

Metric HIND TVRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HIND TVRD Biotechnology median
Market cap 11.44m 11.53m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack